NCT03386851View on ClinicalTrials.gov

Abilify Maintena PMS in Schizophrenia Patients or Bipolar 1 Disorder

CompletedOBSERVATIONAL
Enrollment

1,030

Participants

Timeline

Start Date

December 13, 2016

Primary Completion Date

May 25, 2021

Study Completion Date

May 25, 2021

Conditions
SchizophreniaBipolar 1 Disorder
Trial Locations (1)

Unknown

St.John of God Hospital, Gwangju

Sponsors
All Listed Sponsors
lead

Korea Otsuka Pharmaceutical Co., Ltd.

INDUSTRY